Videobite: Trends Driving Small Molecule Drug Development and Outsourcing
More Content From Videobite: Trends Driving Small Molecule Drug Development and Outsourcing
-
Barcelona Unlocked - Syngene's Insider Guide
Welcome to the ultimate guide to experiencing Barcelona’s charm and culture, tailored exclusively for attendees of CPHI Barcelona.Literature / Brochures Released on 10.13.2023
-
Syngene purchases land to expand operations in Genome Valley, Hyderabad
Syngene plans to build state-of-the-art research laboratories and create up to 1000 jobs.News Releases Released on 09.15.2023
-
Syngene Revenue Up 26% and PAT Up 26% in the First Quarter
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24News Releases Released on 08.01.2023
-
Targeted Protein Degradation
Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.Literature / Brochures Released on 01.18.2021
-
Biologics and Manufacturing
Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.Literature / Brochures Released on 01.15.2021
-
Your Pre-clinical Toxicology Program Needs a Strategy
At Syngene, we have developed a roadmap across pre-IND, IND and NDA that seamlessly integrate the various pre-clinical studies.Case Studies Released on 01.14.2021
-
Chemical Development
Syngene has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.Literature / Brochures Released on 01.14.2021
-
The Dedicated Center
Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.Case Studies Released on 01.13.2021
-
Clinical Development
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.Literature / Brochures Released on 01.13.2021
-
Proactive COVID-19 Testing
By identifying COVID-19 positive cases early on, particularly those that are asymptomatic, we can restrict further transmission of this deadly virus.Case Studies Released on 01.12.2021
-
Commercial Manufacturing
Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates.Literature / Brochures Released on 01.12.2021
-
How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective
Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.Case Studies Released on 01.11.2021
-
Formulation Development
Syngene supports both development and manufacturing of Drug Products from early to late stage.Literature / Brochures Released on 01.11.2021
-
Harnessing Targeted Protein Degradation
Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.Case Studies Released on 01.08.2021
-
ICH Stability Studies
One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.Literature / Brochures Released on 01.08.2021
